why choose us

First received: March 23, 2023

Clinical Trial: Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Randomized, Single-blind, Placebo-controlled, Single/Multiple Dose, Dose Escalation, Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Characteristics of CKR-051 After

Brief Summary: This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of CKR-051 in healthy participants.This study aiming to develop an agent for skin regeneration; potential treatments include acute and chronic wounds (c.f.Diabetic foot ulcers).

Read more